Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects

NCT00966602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-809
DRUG: VX-770
DRUG: VX-809 & VX-770
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated